pMF-FU_TetO_GW_PPARG2
(Plasmid
#193289)
-
PurposeLentiviral construct that expresses a dox-inducible human PPARG2
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 193289 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneFU-tetO-Gateway
-
Backbone manufacturerAddgene plasmid 43914
- Backbone size w/o insert (bp) 10257
- Total vector size (bp) 9962
-
Modifications to backboneRemoval of Gateway cassette and insertion of PPARG2 through gateway recombination
-
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namePPARG2
-
Alt nameNR1C3
-
SpeciesH. sapiens (human)
-
GenBank IDNM_015869.5
-
Entrez GenePPARG2 (a.k.a. HUMPPARG)
- Promoter TRE promoter, Tet-ON
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer LNCX; T7
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMF-FU_TetO_GW_PPARG2 was a gift from Rudolf Jaenisch (Addgene plasmid # 193289 ; http://n2t.net/addgene:193289 ; RRID:Addgene_193289) -
For your References section:
Development of a physiological insulin resistance model in human stem cell-derived adipocytes. Friesen M, Khalil AS, Barrasa MI, Jeppesen JF, Mooney DJ, Jaenisch R. Sci Adv. 2022 Jun 17;8(24):eabn7298. doi: 10.1126/sciadv.abn7298. Epub 2022 Jun 17. 10.1126/sciadv.abn7298 PubMed 35714187